Actuate unveils modest $50M IPO plans to fund further cancer drug trials 17.07.2024 11:46 Fiercebiotech.com Actuate unveils modest $50M IPO plans to fund further cancer drug trials jwaldron Wed, 07/17/2024 - 04:46
